SHELDON KAPLAN to Serogroup
This is a "connection" page, showing publications SHELDON KAPLAN has written about Serogroup.
Connection Strength
0.752
-
Invasive Pneumococcal Disease in Children's Hospitals: 2014-2017. Pediatrics. 2019 09; 144(3).
Score: 0.157
-
Meningococcal Serogroup B Vaccine Immunogenicity in High-Risk Groups: What Are the Implications? Pediatrics. 2018 09; 142(3).
Score: 0.146
-
Invasive Serotype 35B Pneumococci Including an Expanding Serotype Switch Lineage. Emerg Infect Dis. 2018 02; 24(2):405.
Score: 0.141
-
Emergence of Multidrug-Resistant Pneumococcal Serotype 35B among Children in the United States. J Clin Microbiol. 2017 03; 55(3):724-734.
Score: 0.129
-
Multicenter surveillance of Streptococcus pneumoniae isolates from middle ear and mastoid cultures in the 13-valent pneumococcal conjugate vaccine era. Clin Infect Dis. 2015 May 01; 60(9):1339-45.
Score: 0.115
-
Invasive Pneumococcal Disease in Infants Aged 0-60 Days in the United States in the 13-Valent Pneumococcal Conjugate Vaccine Era. J Pediatric Infect Dis Soc. 2018 Aug 17; 7(3):249-252.
Score: 0.037
-
Impact of the 13-valent pneumococcal conjugate vaccine on chronic sinusitis associated with Streptococcus pneumoniae in children. Pediatr Infect Dis J. 2014 Oct; 33(10):1033-6.
Score: 0.028